Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001 Journal Article

  

Authors:	Garon, E. B.; Hellmann, M. D.; Costa, E. C.; Leighl, N. B.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; Gubens, M. A.; Ramalingam, S. S.; Felip, E.; Scalzo, C.; Jensen, E.; Kush, D. A.; Hui, R.
Article Title:	Five-year long-term overall survival for patients with advanced NSCLC treated with pembrolizumab: Results from KEYNOTE-001
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	18
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-06-01
Language:	English
ACCESSION:	WOS:000489109800013
DOI:	10.1200/JCO.2019.37.18_suppl.LBA9015
PROVIDER:	wos
Notes:	Meeting Abstract -- Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2019 -- Chicago, IL -- S -- Source: Wos